Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kira Lutz
Deferasirox in MDS Patients With Transfusion-Caused Iron Overload—a Phase-Ii Study
Annals of Hematology
Medicine
Hematology
Related publications
PO-0161 Treatment of Iron Overload With Deferasirox in the Patients With Thalassaemia Major
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Patient-Reported Outcomes From a Randomized Phase II Study of the Deferasirox Film-Coated Tablet in Patients With Transfusion-Dependent Anemias
Health and Quality of Life Outcomes
Medicine
Environmental
Public Health
Occupational Health
Deferasirox Reduces Oxidative Stress in Patients With Transfusion Dependency
Journal of Clinical Medicine Research
Iron Overload in Non-Transfusion-Dependent Thalassemia
Thalassemia Reports
Maitake Mushroom Extract in Myelodysplastic Syndromes (MDS): A Phase II Study
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Real-World Evidence of Iron Chelation Therapy in Transfusion-Dependent MDS Patients: A Portuguese Hospital Registry
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Hematologic Responses to Deferasirox Therapy in Transfusion-Dependent Patients With Myelodysplastic Syndromes
Haematologica
Hematology
Daily Alternating Deferasirox and Deferiprone Therapy Successfully Controls Iron Accumulation in Untreatable Transfusion Dependent Thalassemia Patients
American Journal of Hematology
Hematology
Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
